The inflammatory reflex

Nature

Volumn 420, Issue 6917, 2002, Pages 853-859

  Tracey, Kevin J ^a  

^a Northwell Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLAMMABILITY; NEUROLOGY;

MICROBIAL INVASION;

HEALTH RISKS;

CYTOKINE; HORMONE; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR BINDING PROTEIN;

MEDICINE;

CHOLINERGIC NERVE CELL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MORBIDITY; NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; SENSORY SYSTEM; VAGUS NERVE STIMULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; HUMANS; INFLAMMATION; NERVOUS SYSTEM PHYSIOLOGY; REFLEX; TUMOR NECROSIS FACTOR-ALPHA; VAGUS NERVE;

EID: 0037180778     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature01321     Document Type: Review

References (81)

1. Tracey, K. J. et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330, 662-664 (1987).
2. Tracey, K. J. et al. Shock and tissue injury induced by recombinant human cachectin. Science 234, 470-474 (1986).
3. Wang, H. et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285, 248-251 (1999).
4. Tracey, K. J., Vlassara, H. & Cerami, A. Cachectin/tumour necrosis factor. Lancet 1, 1122-1126 (1989).
5. Tracey, K. J. & Abraham, E. From mouse to man: Or what have we learned about cytokine-based anti-inflammatory therapies? Shock 11, 224-225 (1999).
6. Andersson, U. et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192, 565-570 (2000).
7. Ulloa, L. et al. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc. Natl Acad. Sci. USA 99, 12351-12356 (2002).
8. Wang, H., Yang, H., Czura, C. J., Sama, A. E. & Tracey, K. J. HMGB1 as a late mediator of lethal systemic inflammation. Am. J. Respir. Crit Care Med. 164, 1768-1773 (2001).
9. Lantz, M., Gullberg, U., Nilsson, E. & Olsson, I. Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor. J. Clin. Invest. 86, 1396 (1990).
10. Tsunawaki, S., Sporn, M., Ding, A. & Nathan, C. Deactivation of macrophages by transforming growth factor-β. Nature 334, 260-262 (1988).
11. Vander, P. T., Coyle, S. M., Barbosa, K., Braxton, C. C. & Lowry, S. F. Epinephrine inhibits tumor necrosis factor-α and potentiates interleukin 10 production during human endotoxemia. J. Clin. Invest 97, 713-719 (1996).
12. Scheinman, R. I., Cogswell, P. C., Lofquist, A. K. & Baldwin, A. S. Jr Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270, 283-286 (1995).
13. Chrousos, G. P. The stress response and immune function: Clinical implications. The 1999 Novera H. Spector Lecture. Ann. NY Acad. Sci. 917, 38-67 (2000).
14. Madden, K. S., Sanders, V. M. & Felten, D. L. Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu. Rev. Pharmacol. Toxicol. 35, 417-448 (1995).
15. Zhang, M., Borovikova, L. V., Wang, H., Metz, C. & Tracey, K. J. Spermine inhibition of monocyte activation and inflammation. Mol. Med. 5, 595-605 (1999).
16. Bertini, R., Bianchi, M. & Ghezzi, P. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J. Exp. Med. 167, 1708-1712 (1988).
17. Butler, L. D. et al. Neuroendocrine regulation of in vivo cytokine production and effects: I. In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumor necrosis factor-α. J. Neuroimmunol. 24, 143-153 (1989).
18. Bloom, O. et al. Hypophysectomy, high tumor necrosis factor levels, and hemoglobinemia in lethal endotoxemic shock. Shock 10, 395-400 (1998).
19. Sternberg, E. M. et al. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc. Natl Acad. Sci. USA 86, 2374-2378 (1989).
20. Webster, J. I., Tonelli, L. & Sternberg, E. M. Neuroendocrine regulation of immunity. Annu. Rev. Immunol. 20, 125-163 (2002).
21. + T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J. Exp. Med. 184, 241-251 (1996).
22. Johansson, A. C., Hansson, A. S., Nandakumar, K. S., Backlund, J. & Holmdahl, R. IL-10-deficient B10. Q mice develop more severe collagen-induced arthritis, but are protected from arthritis induced with anti-type II collagen antibodies. J. Immunol. 167, 3505-3512 (2001).
23. Wexler, BC., Dolgin AE & Tryczynski EW. Effects of a bacterial polysaccharide (Piromen) on the pituitary-adrenal axis: Adrenal ascorbic acid, cholesterol and histologic alterations. Endocrinology 61, 300-308 (1957).
24. Besedovsky, H., Sorkin, E., Felix, D. & Haas, H. Hypothalamic changes during the immune response. Eur. J. Immunol. 7, 323-325 (1977).
25. Blalock, J. E. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Rev. 69, 1-32 (1989).
26. Breder, C. D., Dinarello, C. A. & Saper, C. B. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 240, 321-324 (1988).
27. Breder, C. D. et al. Regional induction of tumor necrosis factor a expression in the mouse brain after systemic lipopolysaccharide administration. Proc. Natl Acad. Sci. USA 91, 11393-11397 (1994).
28. Besedovsky, H., del Rey, A., Sorkin, E. & Dinarello, C. A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233, 652-654 (1986).
29. Watkins, L. R. & Maier, S. F. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev. 82, 981-1011 (2002).
30. Borovikova, L. V. et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405, 458-462 (2000).
31. Bellinger, D. L., Lorton, D., Lubahn, C. & Felten, D. L. in Psychoneuroimmunology (eds Ader R., Felten, D. L. & Cohen, N) 55-112 (Academic, San Diego, 2001).
32. Bernik, T. R. et al. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J. Exp. Med. 195, 781-788 (2002).
33. Borovikova, L. V. et al. Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton. Neurosci. 85, 141-147 (2000).
34. Sato, K. Z. et al. Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines. Neurosci. Lett. 266, 17-20 (1999).
35. Sato, E., Koyama, S., Okubo, Y., Kubo, K. & Sekiguchi, M. Acetykholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity. Am. J. Physiol. 274, L970-L979 (1998).
36. Wessler, I., Kirkpatrick, C. I. & Racke, K. Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: Expression and function in humans. Pharmacol. Ther. 77, 59-79 (1998).
37. Kawashima, K. & Pujii, T. Extraneuronal cholinergic system in lymphocytes. Pharmacol. Ther. 86, 29-48 (2000).
38. Clark, K. B., Naritoku, D. K., Smith, D. C., Browning, R. A. & Jensen, R. A. Enhanced recognition memory following vagus nerve stimulation in human subjects. Nature Neurosci. 2, 94-98 (1999).
39. Blalock, J. E. The immune system as a sensory organ. J. Immunol. 132, 1067-1070 (1984).
40. Blalock, J. E. Shared ligands and receptors as a molecular mechanism for communication between the immune and neuroendocrine systems. Ann. NY Acad. Sci. 741, 292-298 (1994).
41. Goehler, L. E. et al. Vagal immune-to-brain communication: A visceral chemosensory pathway. Auton Neurosci. 85, 49-59 (2000).
42. Hermann, G. E., Emch, G. S., Tovar, C. A. & Rogers, R. C. c-Fos generation in the dorsal vagal complex after systemic endotoxin is not dependent on the vagus nerve. Am. J. Physiol. Regal. Integr. Comp Physiol. 280, R289-R299 (2001).
43. Emch, G. S., Hermann, G. E. & Rogers, R. C. TNF-α activates solitary nucleus neurons responsive to gastric distension. Am. J. Physiol. Gastrointest. Liver Physiol. 279, G582-G586 (2000).
44. Watkins, L. R. & Maier, S. F. Implications of immune-to-brain communication for sickness and pain. Proc. Natl Acad. Sci. USA 96, 7710-7713 (1999).
45. Watkins, L. R. et al. Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: Evidence for vagal mediation of immune-brain communication. Neurosci. Lett. 183, 27-31 (1995).
46. Hansen, M. K. et al. Effects of vagotomy on lipopolysaccharide-induced brain interleukin-1β protein in rats. Auton. Neurosci. 85, 119-126 (2000).
47. Hansen, M. K., O'Connor, K. A., Goehler, L. E., Watkins, L. R. & Maier, S. F. The contribution of the vagus nerve in interleukin-1β-induced fever is dependent on dose. Am. J. Physiol. Regal. Integr. Comp. Physiol. 280, R929-R934 (2001).
48. Romanovsky, A. A. Thermoregulatory manifestations of systemic inflammation: Lessons from vagotomy. Auton. Neurosci. Basic Clin. 85, 39-48 (2000).
49. Goehler, L. E. et al. Vagal paraganglia bind bintinylated interleukin-1 receptor antagonist: A possible mechanism for immune-to-brain communication. Brain Res. Bull. 43, 357-364 (1997).
50. Berthoud, H. R. & Neuhuber, W. L. Functional and chemical anatomy of the afferent vagal system. Auton. Neurosci. 85, 1-17 (2000).
51. Gordon, F. J. Effect of nucleus tractus solitarius lesions on fever produced by interleukin-1β. Auton. Neurosci. 85, 102-110 (2000).
52. Molina, P. E., Bagby, G. J. & Stahls, P. Hemorrhage alters neuroendocrine, hemodynamic, and compartment-specific TNF responses to LPS. Shock 16, 459-465 (2001).
53. Molina, P. E. Noradrenergic inhibition of TNF upregulation in hemorrhagic shock Neuroimmunomodulation 9, 125-133 (2001).
54. Woiciechowsky, C. et al. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nature Med. 4, 808-813 (1998).
55. Koizumi, K., Terui, N., Kollai, M. & Brooks, C. M. Functional significance of coactivation of vagal and sympathetic cardiac nerves. Proc. Natl Acad. Sci. USA 79, 2116-2120 (1982).
56. Bianchi, M. et al. Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone. J. Exp. Med. 183, 927-936 (1996).
57. Bianchi, M. et al. An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality. Mol. Med. 1, 254-266 (1995).
58. Tracey, K. J. Suppression of TNF and other proinflammatory cytokines by the tetravalent guanylhydrazone CNI-1493. Prog. Clin. Biol. Res. 397, 335-343 (1998).
59. Hommes, D. et al. Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease. Gastroenterology 122, 7-14 (2002).
60. Tracey, K. J., Czura, C. J. & Ivanova, S. Mind over immunity. FASEB J. 15, 1575-1576 (2001).
61. Delgado, H. R. et al. Inhibition of systemic inflammation by central action of the neuropeptide α-melanocyte-stimulating hormone. Neuroimmunomodulation 6, 187-192 (1999).
62. Ceriani, G., Macaluso, A., Catania, A. & Lipton, I. M. Central neurogenic antiinflammatory action of α-MSH: Modulation of peripheral inflammation induced by cytokines and other mediators of inflammation. Neuroendocrinology 59, 138-143 (1994).
63. Catania, A., Arnold, J., Macaluso, A., Hiltz, M. E. & Lipton, J. M. Inhibition of acute inflammation in the periphery by central action of salicylates. Proc. Natl Acad. Sci. USA 88, 8544-8547 (1991).
64. Matsumori, A., Ono, K., Nishio, R., Nose, Y. & Sasayama, S. Amiodarone inhibits production of tumor necrosis factor-α by human mononuclear cells: A possible mechanism for its effect in heart failure. Circulation 96, 1386-1389 (1997).
65. Dias, D. S. et al. Opposite effects of iv amiodarone on cardiovascular vagal and sympathetic efferent activities in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R543-R548 (2002).
66. Arai, I., Hirose, H., Muramatsu, M., Okuyama, S. & Aihara, H. Possible involvement of non-steroidal anti-inflammatory drugs in vagal-mediated gastric acid secretion in rats. Jpn. J. Pharmacol. 37, 91-99 (1985).
67. Ben Menachem, E. Vagus nerve stimulation, side effects, and long-term safety. J. Clin. Neurophysiol. 18, 415-418 (2001).
68. Schachter, S. C. Vagus nerve stimulation: Where are we? Curr. Opin. Neurol. 15, 201-206 (2002).
69. Pullan, R. D. et al. Transdermal nicotine for active ulcerative colitis. N. Engl. J. Med. 330, 811-815 (1994).
70. Mabley, J. G., Pacher, P., Southan, G. J., Salzman, A. L. & Szabo, C. Nicotine reduces the incidence of type 1 diabetes in mice. J. Pharmacol. Exp. Ther. 300, 876-881 (2002).
71. Metal'nikov, S. a. V. C. Role des reflexes conditionnels dans l'immunite. Ann. Inst. Pasteur 40, 893-900 (1926).
72. Madden, K. S. & Felten, D. L. Experimental basis for neural-immune interactions. Physiol Rev. 75, 77-106 (1995).
73. Ader R. & Cohen, N. in Psychoneuroimmunology (eds Ader R., Felten, D. L. & Cohen, N) 3-34 (Academic, San Diego, 2001).
74. Exton, M. S. et al. Pavlovian conditioning of immune function: Animal investigation and the challenge of human application. Behav. Brain Res. 110, 129-141 (2000).
75. Black, S. Inhibition of immediate-type hypersensitivity response by direct suggestion under hypnosis. Br. Med. J. 1, 925-929 (1963).
76. Zachariae, R. in Psychoneuroimmunology (eds Ader R., Felten, D. L. & Cohen, N.) 133-160 (Academic, San Diego, 2001).
77. Noguchi, E. & Hayashi, H. Increases in gastric acidity in response to electroacupuncture stimulation of the hindlimb of anesthetized rats. Jpn. J. Physiol 46, 53-58 (1996).
78. Lux, G. et al. Acupuncture inhibits vagal gastric acid secretion stimulated by sham feeding in healthy subjects. Gut 35, 1026-1029 (1994).
79. Toussirot, E., Serratrice, G. & Valentin, P. Autonomic nervous system involvement in rheumatoid arthritis. 50 Cases. J. Rheumatol. 20, 1508-1514 (1993).
80. Tan, J., Akin, S., Beyazova, M., Sepici, V. & Tan, E. Sympathetic skin response and R-R interval variation in rheumatoid arthritis. Two simple tests for the assessment of autonomic function. Am. J. Phys. Med. Rehabil. 72, 196-203 (1993).
81. Edmonds, M. E., Jones, T. C., Saunders, W. A. & Sturrock, R. D. Autonomic neuropathy in rheumatoid arthritis. Br. Med. J. 2, 173-175 (1979).